Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric P Winer

Showing results (31-40 of 465) with videos related to

Pageof 47
Sort By:
Journal of the National Cancer Institute|October 16, 2019
Adjuvant Chemotherapy for Older Patients With Breast Cancer: When Is the Pain Worth the Gain?Rachel A Freedman, Eric P Winer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2008
Optimizing endocrine therapy for estrogen receptor-positive breast cancer: treating the right patients for the right length of timeNancy U Lin, Eric P Winer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Brain metastases: the HER2 paradigmNancy U Lin, Eric P Winer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2015
Tumor-infiltrating lymphocytes and response to platinum in triple-negative breast cancerNadine M Tung, Eric P Winer
Breast (Edinburgh, Scotland)|August 10, 2015
Tailoring adjuvant chemotherapy regimens for patients with triple negative breast cancerDaniel G Stover, Eric P Winer
Breast Disease|February 3, 2005
Long-term complications of adjuvant chemotherapy for early stage breast cancerAnn H Partridge, Eric P Winer
Breast Cancer Research : BCR|August 21, 2004
New targets for therapy in breast cancer: small molecule tyrosine kinase inhibitorsNancy U Lin, Eric P Winer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2005
Ovarian suppression for breast cancer: an effective treatment in search of a homeIan E Krop, Eric P Winer
Breast Cancer Research : BCR|February 7, 2006
Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questionsJennifer A Ligibel, Eric P Winer
Breast Cancer Research and Treatment|May 9, 2008
Ten years of HER2-directed therapy: still questions after all these yearsIan E Krop, Eric P Winer
Pageof 47

Showing results (31-40 of 465) with videos related to

Sort By:
Pageof 47
Journal of the National Cancer Institute|October 16, 2019
Adjuvant Chemotherapy for Older Patients With Breast Cancer: When Is the Pain Worth the Gain?Rachel A Freedman, Eric P Winer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2008
Optimizing endocrine therapy for estrogen receptor-positive breast cancer: treating the right patients for the right length of timeNancy U Lin, Eric P Winer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Brain metastases: the HER2 paradigmNancy U Lin, Eric P Winer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2015
Tumor-infiltrating lymphocytes and response to platinum in triple-negative breast cancerNadine M Tung, Eric P Winer
Breast (Edinburgh, Scotland)|August 10, 2015
Tailoring adjuvant chemotherapy regimens for patients with triple negative breast cancerDaniel G Stover, Eric P Winer
Breast Disease|February 3, 2005
Long-term complications of adjuvant chemotherapy for early stage breast cancerAnn H Partridge, Eric P Winer
Breast Cancer Research : BCR|August 21, 2004
New targets for therapy in breast cancer: small molecule tyrosine kinase inhibitorsNancy U Lin, Eric P Winer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2005
Ovarian suppression for breast cancer: an effective treatment in search of a homeIan E Krop, Eric P Winer
Breast Cancer Research : BCR|February 7, 2006
Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questionsJennifer A Ligibel, Eric P Winer
Breast Cancer Research and Treatment|May 9, 2008
Ten years of HER2-directed therapy: still questions after all these yearsIan E Krop, Eric P Winer
Pageof 47